News

AOL3mon
FDA Approves Sanofi's Hemophilia Drug - AOL
The U.S. Food and Drug Administration on Friday approved Sanofi SA’s (NASDAQ:SNY) Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce ...
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data
Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and ...
New York Post1mon
FDA approves Moderna's next-generation COVID vaccine for adults 65 or older - New York Post
The US Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above. Moderna expects to have the vaccine available for the 2025-2026 ...
The American Journal of Managed Care1mon
FDA Approves Jivi for Pediatric Patients Aged 7 to 12 Years With Hemophilia A
Previously, Jivi was approved in September 2018 for adults and adolescents aged 12 years and older with this hemophilia subtype. 2 According to data collected from federally funded hemophilia ...
Applied Clinical Trials Online4d
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...
UPI1mon
FDA approves Novavax's COVID-19 vaccine with limitations
May 18 (UPI) --The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.The agency approved the vaccine only for people 65 and older ...
PBS1mon
FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use - PBS
WASHINGTON (AP) — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...
NBC Washington1mon
FDA approves Novavax COVID-19 shot but with unusual restrictions
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based ...
CNN1mon
FDA may limit future Covid-19 shots to older people and those at risk of serious infection - CNN
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious ...
NPR1mon
COVID boosters will be updated for next fall and winter : Shots - Health News - NPR
Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should be targeted by updated versions of the vaccines.
Benzinga.com3mon
FDA Approves Sanofi's Hemophilia Drug - Benzinga
FDA approves Sanofi's Qfitlia, the first antithrombin-lowering therapy for hemophilia A or B, reducing bleeding episodes with as few as six injections per year.
Detroit News1mon
FDA approves Novavax COVID-19 shot but with unusual restrictions - The Detroit News
Washington — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.. Novavax makes the nation’s only traditional ...